JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(4):178-182

Voltage gated calcium channels: structure, characteristics and terminology

L. Veizerová, J. Světlík, V. Kettmann
Univerzita Komenského, Farmaceutická fakulta, Katedra farmaceutickej analýzy a nukleárnej farmácie, Bratislava, Slovenská republika

Voltage-gated Ca2+ channels are the major pathway of Ca2+ entry into the cells. Their activity is essential to couple electrical signals from the cell surface to physiological events in cells. Several pharmacologically, structurally and kinetically distinct calcium channel types have been identified at the electrophysiological and molecular levels. This review aims to describe the functional, structural and pharmacological properties of voltage-gated calcium channels.

Keywords: voltage-dependent Ca2+ channels; types of calcium channel proteins; electrophysiology; terminology; subunits

Received: April 25, 2007; Accepted: June 1, 2007; Published: April 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veizerová L, Světlík J, Kettmann V. Voltage gated calcium channels: structure, characteristics and terminology. Čes. slov. farm. 2007;56(4):178-182.
Download citation

References

  1. Triggle, D. J.: Calcium Channel Pharmacology. S.I. McDough, Kluwer Academic/Plenum Publishers, Norwell, 2004, kapitola 3.
  2. Bootman, M. D. et al.: Semin. Cell Dev. Biol., 2001; 12, 3-10. Go to original source...
  3. Campbell, N. A., Reece, J. B.: Biologie. Computer Press, a.s., Brno, 2006, s. 1332.
  4. Albert, B. et al.: Základy buněčné biologie. Espero Publishing, Ústí nad Labem, 1998, s. 386.
  5. Triggle, D. J.: Mini-Rev. Med. Chem., 2003; 3, 215-223. Go to original source... Go to PubMed...
  6. Stotz, S. C. et al.: J. Physiol., 2003; 554, 263-273. Go to original source... Go to PubMed...
  7. Yamamoto, T. et al.: Bioorg. Med. Chem. Lett., 2006; 16, 798-802. Go to original source... Go to PubMed...
  8. Vennekens, R. et al.: Cell Calcium, 2002; 31, 253-254. Go to original source... Go to PubMed...
  9. Weiss, N. et al.: Med. Sci., 2007; 23, 53-63. Go to original source... Go to PubMed...
  10. Almers W., Mc Cleskey E.W.: J. Physiol., 1984; 353, 585-608. Go to original source... Go to PubMed...
  11. Yamakage, M., Namiki A.: Can. J. Anesth., 2002; 49, 151-164. Go to original source... Go to PubMed...
  12. Catterall, W. A. et al.: Pharmacol. Rev., 2005; 57, 411-425. Go to original source... Go to PubMed...
  13. Jones, O. T.: Eur. J. Pharmacol., 2002; 447, 211-225. Go to original source... Go to PubMed...
  14. Josephson, I. R. et al.: Biophys. J., 2002; 83, 2575-2586. Go to original source... Go to PubMed...
  15. Stotz, S.C. et al.: J. Physiol., 2003; 554, 263-273. Go to original source... Go to PubMed...
  16. Livneh, A., Cohen, R., Atlas, D.: Neuroscience, 2006; 139, 1275-1287. Go to original source... Go to PubMed...
  17. Jimenez, C. et al.: Neuropharmacol., 2000; 39, 1-10.
  18. Stotz, S. C., Zamponi, G. W.: Trends Neurosci., 2003; 24 (3), 176-181. Go to original source... Go to PubMed...
  19. Zhang, J. F. et al.: Nature, 1994; 372, 97-100. Go to original source... Go to PubMed...
  20. Sokolov, S. et al.: J. Physiol., 2000; 527, 445-454. Go to original source... Go to PubMed...
  21. Liang, H. et al.: Neuron, 2003; 39, 951-960. Go to original source... Go to PubMed...
  22. Klemic, K. G. et al.: Biophys. J., 1998; 74, 1779-1789. Go to original source... Go to PubMed...
  23. Yu, F. H., Catterall, W. A.: Sci. STKE, 2004; 253, 15. Go to original source... Go to PubMed...
  24. Catterall, W. A.: Annu Rev. Biochem., 1995; 64, 493-531. Go to original source... Go to PubMed...
  25. Triggle, D. J.: Drug Dev. Res., 2003; 58, 5-17. Go to original source...
  26. Furukawa, T. et al.: J. Pharmacol. Exp. Ther., 1999; 291, 464-473. Go to original source...
  27. Catterall, W. A.: Annu. Rev. Cell. Dev. Biolog., 2000; 16, 521-555. Go to original source... Go to PubMed...
  28. Arikkath, J. et al.: Curr. Opin. Neurobiol., 2003; 13, 298-307. Go to original source... Go to PubMed...
  29. Yu, F. H. et al.: Pharmacol. Rev., 2005; 57, 387-391. Go to original source... Go to PubMed...
  30. Mitterdorfer, J. et al.: J. Bioenerg. Biomembr., 1998; 30, 319-334. Go to original source... Go to PubMed...
  31. Schubert-Zsilavecz, M., Stark, H.: Pharm. Unserer Zeit., 2005; 34, 374-379. Go to original source... Go to PubMed...
  32. Jay, S.D. et al.: Science, 1990; 248, 490-492. Go to original source... Go to PubMed...
  33. Letts, E. et al.: Nat. Genet., 1998; 19, 340-347. Go to original source... Go to PubMed...
  34. Arikkath, J. et al.: J. Biol. Chem., 2003; 278, 1212-1219. Go to original source... Go to PubMed...
  35. Chien, A.J. et al.: J. Biol. Chem., 1998; 273, 2359023597.
  36. Bogdanov, Y. et al.: Eur. J. Neurosci., 2000; 12, 894-902. Go to original source... Go to PubMed...
  37. Pragnell, M. et al.: Nature, 1994; 368, 67-70. Go to original source... Go to PubMed...
  38. De Waard, M. et al.: Neuron, 1994; 13, 495-503. Go to original source... Go to PubMed...
  39. Bichet, D. et al.: Neuron, 2000; 25, 177-190. Go to original source... Go to PubMed...
  40. Qin, N. et al.: Mol. Pharmacol., 2004; 62, 485-496. Go to original source...
  41. Klugbauer, N. et al.: J. Neurosci., 1999; 34, 684-691. Go to original source... Go to PubMed...
  42. Gurnett, C.A., De Waard, M., Campbell, K.P.: Neuron, 1996; 16, 431-440. Go to original source... Go to PubMed...
  43. Gurnett, C. A., Felix, R., Campbell, K. P.: J. Biol. Chem., 1997; 272, 18508-18512. Go to original source... Go to PubMed...
  44. Felix, R. et al.: J. Neurosci., 1997; 17, 6884-6891. Go to original source... Go to PubMed...
  45. Birnbaumer, L. et al.: Neuron, 1994; 13, 505-506. Go to original source... Go to PubMed...
  46. Ertel, E. A. et al.: Neuron, 2000; 25, 533-535. Go to original source... Go to PubMed...
  47. Glossman, H., Striessnig, J.: Rev. Physiol. Biochem. Pharmacol., 1990; 114, 1-105.
  48. Lüllmann, H.: Farmakologie a toxikologie. Grada, Praha, 2002, 147.
  49. Miljanich, G. P., Ramachandran, J.: Annu. Rev. Pharmacol. Toxicol., 1995; 35, 707-734. Go to original source... Go to PubMed...
  50. Letter to the Editor: Neuron, 2000; 25, 533-535. Go to original source... Go to PubMed...
  51. McDonough, S. I. et al.: Biophys. J., 1997; 72, 2117-2128. Go to original source... Go to PubMed...
  52. Perez-Reyes, E.: Physiol. Rev., 2003, 83, 117-161. 182 ČESKÁ A SLOVENSKÁ FARMACIE, 2007, 56, č. 4 Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.